Long-Term Follow-up Safety Study of Human Central Nervous System Stem Cells in Subjects With Geographic Atrophy of Age-Related Macular Degeneration
Condition(s):Age-Related Macular Degeneration; Geographic AtrophyLast Updated:June 2, 2016Terminated
Hide Studies Not Open or Pending
Condition(s):Age-Related Macular Degeneration; Geographic AtrophyLast Updated:June 2, 2016Terminated
Condition(s):Age Related Macular Degeneration; Macular Degeneration; AMDLast Updated:September 14, 2015Completed
Condition(s):Age-Related Macular DegenerationLast Updated:June 2, 2016Terminated
Condition(s):Geographic Atrophy of the Macula; Macular DegenerationLast Updated:March 12, 2024Recruiting
Condition(s):Geographic Atrophy; Dry Age Related Macular DegenerationLast Updated:June 22, 2010Completed
Condition(s):Geographic Atrophy; Age Related Macular DegenerationLast Updated:August 13, 2019Withdrawn
Condition(s):Geographic AtrophyLast Updated:February 26, 2024Recruiting
Condition(s):Geographic Atrophy; Macular DegenerationLast Updated:February 23, 2024Completed
Condition(s):Age-Related Macular DegenerationLast Updated:March 27, 2023Recruiting
Condition(s):Age-Related Macular DegenerationLast Updated:January 3, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.